NETRIS Pharma, a French clinical-stage biopharmaceutical startup, has raised an additional €7.5 million in its ongoing Series A round, bringing the total to €24.4 million. This funding, which includes an investment from the EIC Fund, will be used for clinical development and corporate growth.